Elizabeth Kolar

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Very long-chain acyl-CoA synthetase 3 mediates onco-sphingolipid metabolism in malignant glioma”.

Very long-chain acyl-CoA synthetase 3 mediates onco-sphingolipid metabolism in malignant glioma

Medical Research Archives(2021)10.18103/mra.v9i5.2433

N/A

0DataRank · unranked

11 citations

Xiaohai Shi, Emily M. Clay, Ann B. Moser, Bachchu Lal, Raja Sekhar Nirujogi +6 more

VERY LONG-CHAIN ACYL-CoA SYNTHETASE-3 (ACSVL3) PROMOTES THE MALIGNANT GROWTH BEHAVIOR OF U87 GLIOMA CELLS VIA CHANGES IN CELL CYCLE WITHOUT AFFECTING APOPTOSIS

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.05.04.539403

N/A

0DataRank · unranked

1 citations

Xiaohai Shi, Elizabeth Kolar, Emily M. Clay, Shuli Xia, Zhengtong Pei +2 more

Depleting glioblastoma cells of very long-chain acyl-CoA synthetase 3 (ACSVL3) produces metabolic alterations in non-lipid pathways

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.18.558236

N/A

0DataRank · unranked

1 citations

Xiaohai Shi, Emily M. Clay, Yanqiu Liu, Shuli Xia, Cissy Zhang +3 more

Toward pharmacologic therapy for glioblastoma: Identifying inhibitors of very long-chain acyl-CoA synthetase 3 (ACSVL3)

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.07.02.662811

N/A

0DataRank · unranked

0 citations

Xiaohai Shi, Elizabeth Kolar, Mayur D. Mody, John E. Locke, Paul A. Watkins +1 more